Min‐Tsang Hsieh

<scp>YC</scp>‐1 inhibits proliferation of breast cancer cells by down‐regulating <scp>EZH</scp>2 expression via activation of c‐<scp>C</scp>bl and <scp>ERK</scp>

Ling‐Chu Chang, Hui‐Yi Lin, M. Tsai et al. · British Journal of Pharmacology · 2014 · 55 citations · Full text

Medicine, Oncology, Pharmacology +10

Solvent‐ and Transition Metal Catalyst‐Dependent Regioselectivity in the [3+2] Cyclocondensation of Trifluoromethyl<i>‐</i>α,β<i>‐</i>ynones with Hydrazines: Switchable Access to 3‐ and 5‐Trifluoromethylpyrazoles

Min‐Tsang Hsieh, Sheng‐Chu Kuo, Hui‐Chang Lin · Advanced Synthesis & Catalysis · 2015 · 53 citations · Full text

Natural Sciences, Chemistry, Catalysis +9

Discovery of 2-[5-(4-Chloro-phenyl)-1-(2,4-dichloro-phenyl)-4-ethyl-1<i>H</i>-pyrazol-3-yl]-1,5,5-trimethyl-1,5-dihydro-imidazol-4-thione (BPR-890) via an Active Metabolite. A Novel, Potent and Selective Cannabinoid-1 Receptor Inverse Agonist with High Antiobesity Efficacy in DIO Mice

Chien-Huang Wu, Ming‐Shiu Hung, Jen‐Shin Song et al. · Journal of Medicinal Chemistry · 2009 · 42 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Effect of bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell cycle arrest, apoptotic and autophagic pathway in triple-negative breast adenocarcinoma MDA-MB-231 cells: An in vitro study

Ling‐Chu Chang, Min‐Tsang Hsieh, Jai‐Sing Yang et al. · International Journal of Oncology · 2017 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo

Min‐Tsang Hsieh, Ling‐Chu Chang, Hsin‐Yi Hung et al. · European Journal of Medicinal Chemistry · 2017 · 35 citations

Medicine, Medicinal Chemistry, Oncology +8